Activities of Trovafloxacin and Ampicillin-Sulbactam Alone or in Combination versus Three Strains of Vancomycin- Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model

The recent isolation of clinical strains of methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility (MICs, 8 μg/ml) to vancomycin (vancomycin-intermediate S. aureus [VISA]) emphasizes the importance of developing novel antimicrobial regimens and/or agents for future treat...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Aeschlimann, Jeffrey R., Hershberger, Ellie, Rybak, Michael J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89837/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10770744/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.5.1153-1158.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!